PharmiNews

The Directory of Pharma Companies and News

Eli Lilly

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
Category: Pharmaco
Category: Pharmaco

Eli Lilly News

DateNews
2017-01-05Lilly Confirms Date and Conference Call for Fourth-Quarter 2016 Financial Results Announcement
2017-01-05Lilly to Adjust Organization and Leadership Structure to Better Align with Growth Opportunities
2017-01-04U.S. FDA approves supplemental New Drug Applications to include landmark data in product labels for Synjardy® (empaglifl...
2016-12-16Boehringer Ingelheim and Lilly Welcome New Recommendation for Jardiance® (empagliflozin) Tablets in Updated American Dia...
2016-12-16CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Ar...
2016-12-15BASAGLAR® (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S.
2016-12-15Lilly Provides 2017 Financial Guidance and 2016 Update, Reaffirms Financial Expectations Through the Remainder of the De...
2016-12-13Lilly Announces Program to Provide Insulin at Discounted Prices
2016-09-27Lilly to Present Latest Data for Taltz® (ixekizumab) in Psoriasis at the European Academy of Dermatology and Venereology...
2016-09-16CHMP Recommends Approval of Lilly's Olaratumab, in Combination with Doxorubicin, for Advanced Soft Tissue Sarcoma
2016-09-15Boston Mayor Walsh and the Alzheimer's Association, Massachusetts/New Hampshire Chapter, Receive Alzheimer's Readiness A...
2016-09-14Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D....
2016-08-31Jamere Jackson Elected to Lilly Board of Directors
2016-08-22Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's...
2016-08-10Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires
2016-08-10Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib
2016-07-27John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor
2016-07-27New Studies Suggest Relationship between Tau Pathology and Progression of Alzheimer's Disease
2016-07-26Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through the Remainder of the Decade
2016-07-21Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 201...
2016-07-19U.S. FDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include t...
2016-07-13Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
2016-07-12Lilly and Howard University partner on summer Medical Scientific Fellowship
2016-07-06Lilly Diabetes Welcomes Acclaimed Singer/Songwriter Crystal Bowersox as Newest Spokesperson
2016-06-28Lilly Confirms Date And Conference Call For Second-Quarter 2016 Financial Results Announcement
2016-06-28FDA Advisory Committee recommends approval of Jardiance® (empagliflozin) for cardiovascular indication in 12-11 vote
2016-06-27Lilly Convenes Leaders at National Mayor's Conference to Address Impact of Alzheimer's Disease on Local Communities
2016-06-23Diabetes Scholars Foundation Announces 2016 Scholarship Recipients
2016-06-20Lilly Declares Third-Quarter 2016 Dividend
2016-06-14German Supreme Court Grants Lilly Appeal in Alimta® Vitamin Regimen Patent Lawsuit
2016-06-13Aarti Shah named chief information officer
2016-06-12New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) in Combination with Insulin Glargine Improves Glycemic Contro...
2016-06-12New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age group...
2016-06-11New study results show Tradjenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney im...
2016-06-11New Study Findings Underscore Importance of Physician/Patient Communication on Insulin Adherence and Outcomes
2016-06-09Patient-reported outcomes across phase 3 studies of baricitinib demonstrate statistically significant improvements in ph...
2016-06-09Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to con...
2016-06-09Lilly and American Migraine Foundation Announce $1 Million Grant for Launch of First Patient Registry to Advance Researc...
2016-06-09Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase in Overall Survival in Patients with Adv...
2016-06-08Studies Demonstrate Lilly's Taltz® (ixekizumab) Maintained or Achieved High Levels of Skin Clearance for Patients with M...
2016-06-07Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Prese...
2016-06-05Early-Phase Immuno-Oncology Studies of Lilly's ALIMTA® (pemetrexed) and CYRAMZA® (ramucirumab) with Merck's KEYTRUDA® (p...
2016-06-03Lilly Announces Results from MONARCH 1 Trial of Abemaciclib Monotherapy
2016-06-01Lilly Announces Diabetes Commercial Update Investor Call
2016-05-31U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adult...
2016-05-31Lilly Announces Webcast to Discuss Abemaciclib Data
2016-05-25Lilly to Participate in Goldman Sachs 37th Annual Global Healthcare Conference
2016-05-24Lilly Details Robust R&D Pipeline to Investment Community
2016-05-23Lilly to Participate in Bernstein Strategic Decisions Conference
2016-05-19Lilly's First Volunteer Teams of 2016 Depart in May for Thailand and Ghana
2016-05-18ASCO Data Underscore Lilly's Diverse Oncology Pipeline and Portfolio
2016-05-18Lilly partners with Washington University School of Medicine and Meharry Medical College on unique summer research progr...
2016-05-04FDA Grants Priority Review for Lilly's Olaratumab, an Investigational Medicine for Advanced Soft Tissue Sarcoma
2016-05-02Lilly Releases First-Ever Integrated Report
2016-05-02Lilly Declares Second-Quarter 2016 Dividend
2016-05-02Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe Plaque Psoriasis
2016-04-28Lilly to Participate in Bank of America Merrill Lynch 2016 Health Care Conference
2016-04-26Lilly Reports First-Quarter 2016 Results, Revises 2016 Financial Guidance
2016-04-19Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
2016-04-12Lilly to Provide Detailed Update of Pipeline and R&D Strategy at Upcoming Investment Community Meeting
2016-04-08Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's ...
2016-04-04Lilly Confirms Date and Conference Call for First-Quarter 2016 Financial Results Announcement
2016-03-31Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheu...
2016-03-31New 2016 ACC/AHA Guideline Focused Update States that it is Reasonable to Choose Effient® (prasugrel) Over Clopidogrel f...
2016-03-22Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Moderate-to-Severe Plaque Psoriasis
2016-03-15Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
2016-03-07Studies Show Ixekizumab Improved Work Productivity for Patients with Moderate-to-Severe Plaque Psoriasis: Results Publis...
2016-03-07Ixekizumab Demonstrates High Levels of Skin Clearance among Patients with Moderate-to-Severe Plaque Psoriasis Who Did No...
2016-03-04Ixekizumab Demonstrates Rapid, Clinically Meaningful Improvements as Early as One Week among Patients with Moderate-to-S...
2016-03-01Lilly to Present Phase 3 Data at the American Academy of Dermatology (AAD) Annual Meeting for Ixekizumab in Psoriasis an...
2016-02-26Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
2016-02-19Eli Lilly and Company and United Way Announced Global Partnership Agreement
2016-02-12UK Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit
2016-02-11Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation
2016-02-03American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease Management Skills, Conf...
2016-01-28Lilly Reports Fourth-Quarter and Full-Year 2015 Results
2016-01-27Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool
2016-01-27Lilly To Present At Leerink Partners Global Healthcare Conference
2016-01-25U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)
2016-01-21U.S. Food and Drug Administration Approves Humulin® R U-500 KwikPen®
2016-01-19Lilly and Incyte Announce Submission of New Drug Application to FDA for Oral Once-Daily Baricitinib for Treatment of Mod...
2016-01-05Lilly Announces 2016 Financial Guidance, Updates 2015 Expectations
2016-01-04Lilly to Present at J.P. Morgan Healthcare Conference
2015-12-16FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
2015-12-15Juan R. Luciano elected to Lilly board of directors
2015-12-15Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results
2015-12-10Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA® Combination Trial
2015-12-08Lilly Announces Dividend Increase
2015-12-04Lilly Ends Basal Insulin Peglispro Development Program
2015-12-01New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) is Effective as Add-on Treatment to Sulfonylurea
2015-11-24FDA Approves Portrazza™ (necitumumab) for Specific Type of Lung Cancer
2015-11-20Lilly to Provide Detailed Review of Elanco Animal Health and Alzheimer's R&D Strategy at Investment Community Meeting
2015-11-19Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial
2015-11-09New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline
2015-11-08Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint...
2015-11-07Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms o...
2015-11-07Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthrit...
2015-11-06EMPA-REG OUTCOME®: Top-line renal data to be presented during American Society of Nephrology (ASN) Kidney Week 2015
2015-11-05Lilly and United Way Celebrate Deepening Partnership, Community Impact
2015-11-04Results of Two Pivotal Baricitinib Trials to be Presented at 2015 American College of Rheumatology Annual Meeting
2015-11-04Lilly to Participate in Credit Suisse 2015 Healthcare Conference
2015-11-03Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Announce Winners of the My Diabetes Pit Crew Sweepstakes
2015-11-02Eli Lilly and Company Announces Expansion of Indianapolis R&D Headquarters
2015-10-27Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data
2015-10-22Lilly Reports Third-Quarter 2015 Results, Revises 2015 Financial Guidance
2015-10-22Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations
2015-10-21Lilly supports global Dementia Discovery Fund
2015-10-19Lilly Declares Fourth-Quarter 2015 Dividend
2015-10-14Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Ph...
2015-10-14New Type 2 Diabetes Treatment Synjardy® (empagliflozin/metformin hydrochloride) Tablets Now Available in U.S. Pharmacies
2015-10-13Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration
2015-10-13Lilly brings drug development to the classroom with new college course offering
2015-10-12Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease
2015-10-11Lilly and Innovent Biologics Expand Their Strategic Alliance to Include Immuno-Oncology Bispecific Antibodies in China a...
2015-10-09Eli Lilly and Company Expands New York City Research and Development Site
2015-10-09Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions
2015-10-08Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cance...
2015-10-07Lilly Confirms Date and Conference Call for Third-Quarter 2015 Financial Results Announcement
2015-10-07Lilly Joins the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study
2015-10-06Lilly to Showcase Data for Investigational Psoriasis Treatment at 24th European Academy of Dermatology and Venereology C...
2015-09-29Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal Phase 3 Study in Patients with Rheumatoid...
2015-09-28Lilly and Sanofi Reach Settlement Agreement in U.S. Insulin Glargine Litigation
2015-09-28Lilly's CYRAMZA® (ramucirumab) Significantly Improves Progression-Free Survival in Phase II Bladder Cancer Trial
2015-09-15Lilly Announces Webcast to Discuss EMPA-REG OUTCOME® Data
2015-08-27U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes
2015-08-27Lilly to Participate in Morgan Stanley Global Healthcare Conference
2015-08-25Lilly, AACE Mark 10th Anniversary of Hurricane Katrina with Reminder of "My Diabetes Emergency Plan" Checklist
2015-08-25U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent
2015-08-20Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events
2015-08-18Lilly's Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies
2015-08-04Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study
2015-07-23Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center
2015-07-23Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance
2015-07-23Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew
2015-07-22Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alz...
2015-07-22New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated f...
2015-07-14Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
2015-07-09Lilly Statement on FDA Advisory Committee Review of Necitumumab
2015-07-01Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement
2015-06-29Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma
2015-06-25Diabetes Scholars Foundation Announces 2015 Scholarship Recipients
2015-06-25UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
2015-06-19CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology
2015-06-17Lilly's investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study
2015-06-17Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational ...
2015-06-17Lilly and Dana-Farber Cancer Institute Announce Research Collaboration
2015-06-15Lilly Declares Third-Quarter 2015 Dividend
2015-06-11Lilly Announces Webcast to Discuss Ixekizumab Phase III Data
2015-06-10Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Week...
2015-06-10Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis
2015-06-08New Data Show Superiority of Lilly's Once-Weekly Trulicity™ (dulaglutide) to Lantus® (insulin glargine) in Patients with...
2015-06-08Olympian Kris Freeman and NASCAR Driver Ryan Reed to Share Their Courageous Stories with Children Who Have Type 1 Diabet...
2015-06-06Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (lira...
2015-06-06Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type...
2015-06-06Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes
2015-06-04Lilly to Present Pivotal Phase 3 Study Results for Investigational Psoriasis Treatment at 23rd World Congress of Dermato...
2015-06-04Lilly commits 780,000 additional vials of insulin to Life for a Child
2015-05-29Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors
2015-05-29Lilly to Participate in Goldman Sachs Global Healthcare Conference
2015-05-28PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting
2015-05-28Lilly to Present CYRAMZA® (ramucirumab) Data at 2015 ASCO Annual Meeting
2015-05-28Lilly Announces the Early Results of Its Cash Tender Offer
2015-05-28Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data
2015-05-28Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outs...
2015-05-27U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®
2015-05-27Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's ...
2015-05-27Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions
2015-05-27Lilly Sends Employees to Serve in Vulnerable Communities around the World
2015-05-14Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies
2015-05-12Lilly Announces Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities a...
2015-05-11Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies
2015-05-06Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts
2015-05-04Lilly Releases Corporate Responsibility, Global Health Reports
2015-05-04Lilly Declares Second-Quarter 2015 Dividend
2015-05-01Lilly to Participate in Bank of America Merrill Lynch Health Care Conference
2015-04-28Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed
2015-04-24Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval
2015-04-23Lilly Reports First-Quarter 2015 Results
2015-04-20Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015
2015-04-20Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis
2015-04-01Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement
2015-03-30Lilly Announces Date for Diabetes Investor Meeting
2015-03-30Preparation Is Personal for Those with Chronic Illnesses
2015-03-23First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. ...
2015-03-23Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab
2015-03-20Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China an...
2015-03-19Lilly and Hanmi Announce an Exclusive License and Collaboration Agreement for the Development and Commercialization of a...
2015-03-06German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit
2015-03-04Lilly and IU School of Medicine Partner on Rotation Program for Medical Students
2015-03-03Lilly to Participate in Barclays Global Healthcare Conference
2015-02-24Lilly to Present at Cowen Health Care Conference
2015-02-23Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3 Study
2015-02-23Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
2015-02-21NASCAR Driver Ryan Reed Takes First Place At Daytona International Speedway
2015-02-19Lilly Provides Update on Evacetrapib Phase 3 Trial
2015-02-11Students with Type 1 Diabetes Get a Boost from Lilly Diabetes to Attend College
2015-02-06Lilly to Present at Leerink Global Healthcare Conference
2015-02-04The Lilly Foundation Commits $1 Million to Support AMPATH Oncology Institute in Kenya
2015-02-03Lilly Diabetes Donates $92,000 in Camp Scholarships to the American Diabetes Association
2015-02-02U.S. FDA approves first-in-class Glyxambi® (empagliflozin/linagliptin) tablets for adults with type 2 diabetes
1970-01-01Biogaran takes over Swipha’s activities in Nigeria to produce generic drugs for the local market
1970-01-01OSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.